Formulation and evaluation of Olmesartan dispersable tablets by using solid dispersion method

Kumar, Otra; Prameela Rani, A.
December 2012
Journal of Pharmacy Research;2012, Vol. 5 Issue 12, p5464
Academic Journal
Olmesartan is a novel and widely prescribed antihypertensive drug which belongs to BCS Class II (Biopharmaceutics Classification System), i.e. having good permeability and poor aqueous solubility. The objectives of present study is to enhance the solubility of Olmesartan by preparing solid dispersion by using carriers such as PVP, PEG, Mannitol and formulate solid dispersion dispersable tablets.


Related Articles

  • Comparative in vitro evaluation of commercially available rabeprazole tablets. Most. Umme Bushra; Rahman, Farjana; Md Aftab Saleh Aziz; Mohammad Morsadul Islam // Der Pharmacia Sinica;2013, Vol. 4 Issue 6, p28 

    The main aim of present investigation was to study some physico-chemical properties( thickness ,hardness, weight variation, friability and disintegration) and in vitro dissolution of most commercially available formulations of rebeprazole (encoded with RPZ-1, RPZ-2,RPZ-3) in Bangladesh and two...

  • Preparation and evaluation of orally disintegrating tablets of Telmisartan with pH independent release. Sujitha, M.; Mariappan, GeethaThanga; Rathnanand, Mahalaxmi // International Journal of PharmTech Research;Jul-Sep2012, Vol. 4 Issue 3, p1154 

    The objective of the study is to optimize, formulate and evaluate orally disintegrating tablet (ODT) of Telmisartan which disintegrates with in few seconds there by having better patient compliance, and achieve drug release independent of pH. Telmisartan(Angiotensin Receptor Blocker, ARB) is an...

  • Formulation development and evaluation of orally disintegrating tablets of doxazosin mesylate. Chaudhari, Shilpa P.; Kotian, Neeraj R.; Bhadgale, Mahesh M.; Bafna, Vardhman C. // Asian Journal of Pharmaceutics;Oct-Dec2012, Vol. 6 Issue 4, p266 

    Doxazosin mesylate has some of the ideal characteristics required for an orally disintegrating tablet. There were some challenges faced during this formulation development. The aims of the present research were to mask the bitter taste of Doxazosin mesylate and to formulate orally disintegrating...

  • DEVELOPMENT AND EVALUATION OF FAST DISSOLVING TABLETS USING DOMPERIDONE: PEG 6000 SOLID DISPERSIONS. Bhatt, Shailendra; Trivedi, Priti // International Journal of Pharmacy & Pharmaceutical Sciences;Oct2012 Supplement, Vol. 4, p246 

    Domperidone is water insoluble anti emetic drug, with problems of variable bioavailability and bio- in equivalence related to its poor water solubility. The purpose of present investigation to increase the dissolution rate of domperidone by developing domperidone tablet, allowing fast,...

  • Two New Formulations for Onfi Launched.  // MPR - Pediatricians' Edition;Fall/Winter2013, Vol. 24 Issue 2, pA5 

    The article reports on the launch of Onfi or clobazam scored tablets and oral suspensiondrug formulations by Lundbeck Pharmaceutical Ltd.

  • Review on Bioavailability and Bioequivalence Studies. Venkateswarlu, Kambham; Thirumaran, J. // International Journal of Pharmaceutical Sciences Review & Resear;Jan/Feb2013, Vol. 18 Issue 1, p56 

    Bioavailability is used to describe the fraction of an administered dose of medication that reaches the systemic circulation, one of the principal properties of the drug. By definition, when the drug is administered intravenously, its bioavailability is 100%. Bioequivalence studies compare both...

  • Drug/Cyclodextrin Solid Systems in the Design of Hydrophilic Matrices: A Strategy to Modulate Drug Delivery Rate. Miro, Agnese; Quaglia, Fabiana; Giannini, Lucia; Cappello, Brunella; La Rotonda, Maria Immacolata // Current Drug Delivery;Oct2006, Vol. 3 Issue 4, p373 

    The aim of this study was to investigate how the delivery rate of erodible sustained-release hydrophilic matrices intended for the delivery of poorly soluble drugs can be optimized through the incorporation of drug/cyclodextrin binary systems. Carvedilol (CAR), a sparingly water-soluble...

  • Encapsulation of Commercially Available Losartan for Blinding Purposes Does Not Affect its Bioavailability. Nyman, L.; Taure, K.; Cullberg, M.; Lagerström P.-O. // Clinical Drug Investigation;1998, Vol. 15 Issue 4, p361 

    Investigates whether encapsulation affects the bioavailability of antihypertensive drug losartan. Bioequivalence of the encapsulated and standard tablets; Drug concentration assessments; Pharmacokinetics; Tolerability analysis.

  • Brand to brand variation in the disintegrant functionality of Polacrilin Potassium, NF. Bele, Mrudula H.; Derle, Diliprao V. // Journal of Excipients & Food Chemicals;2011, Vol. 2 Issue 3, p53 

    The current monograph for Polacrilin Potassium, NF does not specify tests that could assist in distinguishing between different brands of this disintegrant. The objective of this work was to examine the physical characteristics of four brands of Polacrilin Potassium, NF and relate the observed...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics